Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aileron Therapeutics Inc
ALRNCurrent price
3.61 USD
-0.07 USD (-1.90%)
Last closed
3.7 USD
Company
www.aileronrx.com
ISIN
US00887A1051
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
78 430 192 USD
Yield for 12 month
+182.03 %
1Y
3Y
5Y
10Y
15Y
ALRN
Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is headquartered in Austin, Texas. Address: 12407 N. Mopac Expy., Austin, TX, United States, 78758
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+134 000 USD
Current Year
-119 000 USD
Last Year
-169 000 USD
Current Quarter
-4 000 USD
Last Quarter
-59 000 USD
Key Figures ALRN
1 year
3 years
5 years
10 years
EBITDA
-25 396 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.86 %
PEG Ratio
–
Return On Equity TTM
-44.32 %
Wall Street Target Price
13 USD
Revenue TTM
–
Book Value
2.59 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-17 008 000 USD
Earnings per share
-3.1 USD
Diluted Eps TTM
-3.1 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALRN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
11.11.2022
Dividend Date
–
Stock Valuation ALRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.6412
Price Book MRQ
1.4001
Financials ALRN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALRN
For 52 weeks
1.01 USD
7.42 USD
50 Day MA
2.77 USD
Shares Short Prior Month
257 059
200 Day MA
3.81 USD
Short Ratio
2.88
Shares Short
297 745
Short Percent
1.38 %
BeatStart